Tag: haematologic
AstraZeneca to acquire China’s Gracell Biotechnologies for US $1.2 billion
The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a potential new treatment for multiple myeloma, as well as other haematologic malignancies and autoimmune diseases